A survival study of surgically treated lung cancer in Korea
Journal of Korean Medical Science
;
: 135-145, 1991.
Article
in English
| WPRIM
| ID: wpr-90441
ABSTRACT
Survival rate over a 5-year period were studied in a series of 658 proven primary lung cancer patients treated by thoracic surgeons at 8 institutes during the period from 1976 to 1987 in Korea. The study was designed as a multi-center cooperative work for the statistical analysis of the followup result. Clinical data of age, sex, morbidity, and staging of the tumor were assessed in 540 patients to evaluate their 5-year survival rates. Eventually, 405 resectable patients were analyzed by stage, cell type, surgical procedure, and TNM status. The 5-year actuarial survival rates by stage in the resectable group were stage I 39.7%, II 30.6% III A 16.3%, III B 6.7%, and IV 0%. The 5-year survival rates by cell type were squamous cell 31.9%, adenocarcinoma 21.2%, large cell 11%, and small cell 6%. The survival rates by surgical procedures were lobectomy 30.7% and pneumonectomy 25.7%. The survival rates by TNM status in the operable group were T1 34.7%, T2 26.8%, T3 7.5%, T4 5%; N1 23%, N2 10%, N3 3%; MO 21%, and M1 0%, respectively. The overall actuarial 5-year survival rate in the group of 405 resectable patients was 25.9%.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Survival Rate
/
Korea
/
Lung Neoplasms
/
Neoplasm Staging
Type of study:
Controlled clinical trial
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
English
Journal:
Journal of Korean Medical Science
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS